UK Earnings, Trading Statements Calendar | |
Friday, January 30 | |
Fuller,Smith & Turner | Trading Update |
BT Group | Q3 Results |
Vedanta Resources | Q3 Production Results |
James Halstead | Trading Statement |
KCOM Group | Trading Statement |
Monday, February 2 | |
RM | Full Year Results |
Tuesday, February 3 | |
BG Group | Full Year Results |
BP | Full Year Results |
Ocado Group | Full Year Results |
Aberdeen Asset Management | Q1 Trading Statement |
Alumasc Group | Half Year Results |
Low & Bonar | Full Year Results |
St Modwen Property | Full Year Results |
TalkTalk Telecom Group | Interim Management Statement |
Wednesday, February 4 | |
GlaxoSmithKline | Full Year Results |
Hargreaves Lansdown | Half Year Results |
International Consolidated Airlines Group | January Traffic Statistics |
Sky | Half Year Results |
Victrex | Interim Management Statement |
Daily Mail and General Trust | Trading Statement |
GW Pharmaceuticals | Q1 Results |
Thursday, February 5 | |
Fusionex International | Full Year Results |
McBride | Interim Results |
Compass Group | Interim Management Statement |
Beazley | Full Year Results |
AstraZeneca | Full Year Results |
EasyJet | January Traffic Statistics |
Dairy Crest Group | Interim Management Statement |
Future | Interim Management Statement |
Enterprise Inns | Interim Management Statement |
Grainger | Interim Management Statement |
Smith & Nephew | Full Year Results |
Vodafone Group | Interim Management Statement |
Avanti Communications Group | Half Year Results |
Copyright 2015 Alliance News Limited. All Rights Reserved. | |
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.
Read more